Drug Research

The recognition of a previously unidentified genetic cause of late-onset cerebellar ataxia is reported in a new study that was released recently in the New England Journal of Medicine. This finding will help with the diagnosis and open up...

Antibiotic usage is crucial in the treatment of many bacterial infections. However, the quantity of bacteria strains that are impervious to numerous antibiotics is increasing as a result of ongoing overuse and misuse, which is hurting millions of people...

The generic version of the COVID-19 oral antiviral therapy candidate nirmatrelvir has been approved by the World Health Organization Prequalification of Medicines Program (WHO PQ), as stated by the Indian pharmaceutical company Hetero. This is the first prequalification for a...

Researchers in Singapore have identified a brand-new therapeutic target called ADAM10 that may be used to treat people who have diabetic retinopathy (DR), a disorder that is brought on by untreated diabetes and results in blindness. A typical symptom of...

Eli Lilly and Company and ProQR Therapeutics N.V. announced the expansion of their licensing and collaboration agreement focused on the discovery, development and commercialization of new genetic medicines. The collaboration, originally announced in September 2021, applied ProQR’s proprietary Axiomer® RNA editing...

Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand its testing and development capabilities. While the company’s primary service offering is sterile filtration and filling of parenterals, BSM also provides...

Global contract development and manufacturing organization Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation. Located within its facility in Monteggio, Switzerland, the new R&D department will specialize...